TAK-828
Sponsors
Takeda
Conditions
Dose Finding StudyHealthy Volunteers
Phase 1
Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants
CompletedNCT02706834
Start: 2016-03-01End: 2016-06-17Updated: 2018-10-19
A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of TAK-828 Escalating Multiple-Doses in Healthy Participants
TerminatedNCT02817516
Start: 2016-06-30End: 2016-08-22Updated: 2019-07-17